Dear Valued Client,
We are thrilled to announce a significant milestone in our commitment to providing you with a best-in-class OTC trading experience. Effective immediately, our legacy platform, HTS (https://hts.sg), also known as Polaris, has been officially merged and upgraded into the new, unified HashKey website.
This strategic merger unites the strengths of both platforms into a single, powerful, and seamless portal designed to streamline your trading journey from start to finish.
A Unified and Upgraded Trading Experience
The new HashKey OTC platform is more than just a new look; it's a comprehensive upgrade built with your needs in mind. Key new features and improvements include:
- Streamlined Online Onboarding: Enjoy a faster, fully digital account opening and verification process, getting you to trading in less time.
- Integrated Deposit & Withdrawal: Manage your funds effortlessly with the intuitive and secure wallet system for deposits and withdrawals directly within the platform.
- Efficient RFQ (Request-for-Quote) System: Source competitive prices instantly to get the best available rates for your trades.
- Comprehensive Trade Statements: Access and download detailed trade statements and reports with ease for simplified portfolio management and reconciliation.
What This Means For You
Your immediate action is required:
New Login URL: Please update your bookmarks and use the new website to access your account:
Your login credentials remain the same. You will be guided through any necessary steps upon your first login.
We Are Here to Support You
We are confident that you will find the new HashKey OTC platform to be a major step forward in efficiency, security, and user experience.
Should you have any questions, require assistance logging in, or wish to learn more about the new features, please do not hesitate to contact our dedicated support team.
Thank you for your continued trust and partnership. We look forward to serving you on our new and improved platform.
Sincerely,
The HashKey OTC Team
Comments
0 comments
Please sign in to leave a comment.